But even a tiny benefit, restricted to skin cancers in healthy male doctors—but not prostate cancers, alas—is good news for the supplement industry. Supplement sellers are eager to make sure you don’t miss this research.
The study results came out on October 18. Pfizer, the maker of the Centrum Silver pills used in the study, placed this ad in the New York Times on October 19:
But that’s not all. CVS pharmacy sent me this personal e-mail message:
Pfizer, of course, could not be happier.
Why do I think this is about marketing, not public health?
Next public appearance
This will be the closing keynote to the 7th Biennial Childhood Obesity Conference, sponsored by the California Department of Public Health, UC Berkeley, the Atkins Center for Weight and Health, the California Department of Education, Kaiser Permanente, and the California Endowment.
It’s at about 11:30 a.m. in the Long Beach Convention Center.